{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,10]],"date-time":"2026-11-10T06:48:15Z","timestamp":1794293295518,"version":"4.9.0"},"reference-count":47,"publisher":"American Society of Hematology","issue":"23","content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2010,12,2]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Patients with thymic malignancy have high rates of autoimmunity leading to a variety of autoimmune diseases, most commonly myasthenia gravis caused by anti-acetylcholine receptor autoantibodies. High rates of autoantibodies to cytokines have also been described, although prevalence, spectrum, and functionality of these anti-cytokine autoantibodies are poorly defined. To better understand the presence and function of anti-cytokine autoantibodies, we created a luciferase immunoprecipitation system panel to search for autoantibodies against 39 different cytokines and examined plasma from controls (n = 30) and patients with thymic neoplasia (n = 17). In this screen, our patients showed statistically elevated, but highly heterogeneous immunoreactivity against 16 of the 39 cytokines. Some patients showed autoantibodies to multiple cytokines. Functional testing proved that autoantibodies directed against interferon-\u03b1, interferon-\u03b2, interleukin-1\u03b1 (IL-1\u03b1), IL-12p35, IL-12p40, and IL-17A had biologic blocking activity in vitro. All patients with opportunistic infection showed multiple anti-cytokine autoantibodies (range 3-11), suggesting that anti-cytokine autoantibodies may be important in the pathogenesis of opportunistic infections in patients with thymic malignancy. This study was registered at http:\/\/clinicaltrials.gov as NCT00001355.<\/jats:p>","DOI":"10.1182\/blood-2010-05-286161","type":"journal-article","created":{"date-parts":[[2010,8,18]],"date-time":"2010-08-18T02:53:32Z","timestamp":1282100012000},"page":"4848-4858","update-policy":"https:\/\/doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":152,"title":["Anti-cytokine autoantibodies are associated with opportunistic infection in patients with thymic neoplasia"],"prefix":"10.1182","volume":"116","author":[{"given":"Peter D.","family":"Burbelo","sequence":"first","affiliation":[{"name":"Neurobiology and Pain Therapeutics, Laboratory of Sensory Biology, National Institute of Dental and Craniofacial Research, National Institutes of Health (NIH), Bethesda, MD;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah K.","family":"Browne","sequence":"additional","affiliation":[{"name":"Laboratory of Clinical Infectious Diseases, National Institute of Allergy and Infectious Diseases, NIH, Bethesda, MD;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth P.","family":"Sampaio","sequence":"additional","affiliation":[{"name":"Laboratory of Clinical Infectious Diseases, National Institute of Allergy and Infectious Diseases, NIH, Bethesda, MD;"},{"name":"Leprosy Laboratory, Oswaldo Cruz Institute, FIOCRUZ, Manguinhos, Rio de Janeiro, Brazil;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giuseppe","family":"Giaccone","sequence":"additional","affiliation":[{"name":"Medical Oncology Branch, National Cancer Institute, NIH, Bethesda, MD; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rifat","family":"Zaman","sequence":"additional","affiliation":[{"name":"Laboratory of Clinical Infectious Diseases, National Institute of Allergy and Infectious Diseases, NIH, Bethesda, MD;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ervand","family":"Kristosturyan","sequence":"additional","affiliation":[{"name":"Laboratory of Clinical Infectious Diseases, National Institute of Allergy and Infectious Diseases, NIH, Bethesda, MD;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arun","family":"Rajan","sequence":"additional","affiliation":[{"name":"Medical Oncology Branch, National Cancer Institute, NIH, Bethesda, MD; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Ding","sequence":"additional","affiliation":[{"name":"Laboratory of Clinical Infectious Diseases, National Institute of Allergy and Infectious Diseases, NIH, Bethesda, MD;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kathryn H.","family":"Ching","sequence":"additional","affiliation":[{"name":"Neurobiology and Pain Therapeutics, Laboratory of Sensory Biology, National Institute of Dental and Craniofacial Research, National Institutes of Health (NIH), Bethesda, MD;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arlene","family":"Berman","sequence":"additional","affiliation":[{"name":"Medical Oncology Branch, National Cancer Institute, NIH, Bethesda, MD; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joao B.","family":"Oliveira","sequence":"additional","affiliation":[{"name":"Immunology Service, Department of Laboratory Medicine, NIH Clinical Center, Bethesda, MD"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amy P.","family":"Hsu","sequence":"additional","affiliation":[{"name":"Neurobiology and Pain Therapeutics, Laboratory of Sensory Biology, National Institute of Dental and Craniofacial Research, National Institutes of Health (NIH), Bethesda, MD;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caitlin M.","family":"Klimavicz","sequence":"additional","affiliation":[{"name":"Neurobiology and Pain Therapeutics, Laboratory of Sensory Biology, National Institute of Dental and Craniofacial Research, National Institutes of Health (NIH), Bethesda, MD;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael J.","family":"Iadarola","sequence":"additional","affiliation":[{"name":"Neurobiology and Pain Therapeutics, Laboratory of Sensory Biology, National Institute of Dental and Craniofacial Research, National Institutes of Health (NIH), Bethesda, MD;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven M.","family":"Holland","sequence":"additional","affiliation":[{"name":"Laboratory of Clinical Infectious Diseases, National Institute of Allergy and Infectious Diseases, NIH, Bethesda, MD;"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"234","reference":[{"issue":"6","key":"2019111810033750000_B1","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1084\/jem.190.6.875","article-title":"Idiopathic pulmonary alveolar proteinosis as an autoimmune disease with neutralizing antibody against granulocyte\/macrophage colony-stimulating factor.","volume":"190","author":"Kitamura","year":"1999","journal-title":"J Exp Med"},{"issue":"4","key":"2019111810033750000_B2","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1016\/S1074-7613(01)00218-7","article-title":"GM-CSF regulates alveolar macrophage differentiation and innate immunity in the lung through PU. 1.","volume":"15","author":"Shibata","year":"2001","journal-title":"Immunity"},{"issue":"10","key":"2019111810033750000_B3","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1056\/NEJM199603073341004","article-title":"Autoantibodies against erythropoietin in a patient with pure red-cell aplasia.","volume":"334","author":"Casadevall","year":"1996","journal-title":"N Engl J Med"},{"issue":"7","key":"2019111810033750000_B4","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1056\/NEJMoa011931","article-title":"Pure red-cell aplasia and antierythropoietin antibodies in patients treated with recombinant erythropoietin.","volume":"346","author":"Casadevall","year":"2002","journal-title":"N Engl J Med"},{"issue":"1","key":"2019111810033750000_B5","doi-asserted-by":"crossref","first-page":"e10","DOI":"10.1086\/380453","article-title":"Autoantibodies to interferon-\u03b3 in a patient with selective susceptibility to mycobacterial infection and organ-specific autoimmunity.","volume":"38","author":"Doffinger","year":"2004","journal-title":"Clin Infect Dis"},{"issue":"2","key":"2019111810033750000_B6","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1182\/blood-2003-04-1065","article-title":"Naturally occurring anti-IFN-gamma autoantibody and severe infections with Mycobacterium cheloneae and Burkholderia cocovenenans.","volume":"103","author":"Hoflich","year":"2004","journal-title":"Blood"},{"issue":"9","key":"2019111810033750000_B7","doi-asserted-by":"crossref","first-page":"2480","DOI":"10.1172\/JCI19316","article-title":"Acquired predisposition to mycobacterial disease due to autoantibodies to IFN-gamma.","volume":"115","author":"Kampmann","year":"2005","journal-title":"J Clin Invest"},{"issue":"7","key":"2019111810033750000_B8","doi-asserted-by":"crossref","first-page":"4769","DOI":"10.4049\/jimmunol.175.7.4769","article-title":"Anti-IFN-gamma autoantibodies in disseminated nontuberculous mycobacterial infections.","volume":"175","author":"Patel","year":"2005","journal-title":"J Immunol"},{"issue":"5","key":"2019111810033750000_B9","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1016\/S1074-7613(03)00291-7","article-title":"Beneficial autoimmunity to proinflammatory mediators restrains the consequences of self-destructive immunity.","volume":"19","author":"Wildbaum","year":"2003","journal-title":"Immunity"},{"issue":"4","key":"2019111810033750000_B10","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1007\/s11748-007-0185-8","article-title":"Immunological function of thymoma and pathogenesis of paraneoplastic myasthenia gravis.","volume":"56","author":"Okumura","year":"2008","journal-title":"Gen Thorac Cardiovasc Surg"},{"issue":"8","key":"2019111810033750000_B11","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1016\/S0344-0338(99)80002-8","article-title":"The role of T-cells in the initiation of autoantibody responses in thymoma patients.","volume":"195","author":"Vincent","year":"1999","journal-title":"Pathol Res Pract"},{"issue":"2","key":"2019111810033750000_B12","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1191\/096120300678828055","article-title":"Thymoma associated with systemic lupus erythematosus and immunologic abnormalities.","volume":"9","author":"Bozzolo","year":"2000","journal-title":"Lupus"},{"issue":"3","key":"2019111810033750000_B13","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1111\/j.1365-2141.2006.06295.x","article-title":"Pure red cell aplasia associated with thymoma: clinical insights from a 50-year single-institution experience.","volume":"135","author":"Thompson","year":"2006","journal-title":"Br J Haematol"},{"issue":"9091","key":"2019111810033750000_B14","doi-asserted-by":"crossref","first-page":"1596","DOI":"10.1016\/S0140-6736(05)64012-3","article-title":"Spontaneous neutralising antibodies to interferon-alpha and interleukin-12 in thymoma-associated autoimmune disease.","volume":"350","author":"Meager","year":"1997","journal-title":"Lancet"},{"issue":"1","key":"2019111810033750000_B15","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1046\/j.1365-2249.2003.02113.x","article-title":"Anti-cytokine autoantibodies in autoimmunity: preponderance of neutralizing autoantibodies against interferon-alpha, interferon-omega and interleukin-12 in patients with thymoma and\/or myasthenia gravis.","volume":"132","author":"Meager","year":"2003","journal-title":"Clin Exp Immunol"},{"issue":"4","key":"2019111810033750000_B16","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1016\/j.bbrc.2006.11.140","article-title":"Rapid antibody quantification and generation of whole proteome antibody response profiles using LIPS (luciferase immunoprecipitation systems).","volume":"352","author":"Burbelo","year":"2007","journal-title":"Biochem Biophys Res Commun"},{"issue":"3","key":"2019111810033750000_B17","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1128\/CVI.00350-08","article-title":"Serological diagnosis of human herpes simplex virus type 1 and 2 infections by luciferase immunoprecipitation system assay.","volume":"16","author":"Burbelo","year":"2009","journal-title":"Clin Vaccine Immunol"},{"issue":"7","key":"2019111810033750000_B18","doi-asserted-by":"crossref","first-page":"2298","DOI":"10.1128\/JCM.00490-08","article-title":"Rapid, novel, specific, high-throughput assay for diagnosis of Loa loa infection.","volume":"46","author":"Burbelo","year":"2008","journal-title":"J Clin Microbiol"},{"issue":"3","key":"2019111810033750000_B19","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1086\/589718","article-title":"A luciferase immunoprecipitation systems assay enhances the sensitivity and specificity of diagnosis of Strongyloides stercoralis infection.","volume":"198","author":"Ramanathan","year":"2008","journal-title":"J Infect Dis"},{"key":"2019111810033750000_B20","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1186\/1472-6750-5-22","article-title":"A simplified immunoprecipitation method for quantitatively measuring antibody responses in clinical sera samples by using mammalian-produced Renilla luciferase-antigen fusion proteins.","volume":"5","author":"Burbelo","year":"2005","journal-title":"BMC Biotechnol"},{"issue":"1","key":"2019111810033750000_B21","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.bbrc.2007.11.077","article-title":"High definition profiling of autoantibodies to glutamic acid decarboxylases GAD65\/GAD67 in stiff-person syndrome.","volume":"366","author":"Burbelo","year":"2008","journal-title":"Biochem Biophys Res Commun"},{"issue":"6","key":"2019111810033750000_B22","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1080\/08916930902911738","article-title":"Sensitive and robust luminescent profiling of anti-La and other autoantibodies in Sjogren's syndrome.","volume":"42","author":"Burbelo","year":"2009","journal-title":"Autoimmunity"},{"issue":"32","key":"2019111810033750000_B23","first-page":"pii","article-title":"Antibody profiling by luciferase immunoprecipitation systems (LIPS).","author":"Burbelo","year":"2009","journal-title":"J Vis Exp"},{"issue":"4","key":"2019111810033750000_B24","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1086\/515670","article-title":"Abnormal regulation of interferon-gamma, interleukin-12, and tumor necrosis factor-alpha in human interferon-\u03b3 receptor 1 deficiency.","volume":"178","author":"Holland","year":"1998","journal-title":"J Infect Dis"},{"issue":"3","key":"2019111810033750000_B25","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1006\/clim.2001.5078","article-title":"Detection of intracellular phosphorylated STAT-4 by flow cytometry.","volume":"100","author":"Uzel","year":"2001","journal-title":"Clin Immunol"},{"issue":"11","key":"2019111810033750000_B26","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1006\/cyto.1997.0240","article-title":"Molecular characterization of the human interleukin (IL)-17 receptor.","volume":"9","author":"Yao","year":"1997","journal-title":"Cytokine"},{"key":"2019111810033750000_B27","first-page":"148","volume-title":"World Health Organization Classification of Tumours Pathology and Genetics of Tumours of the Lung, Pleura, Thymus and Heart","author":"Travis","year":"2004"},{"issue":"5","key":"2019111810033750000_B28","doi-asserted-by":"crossref","first-page":"1755","DOI":"10.1084\/jem.181.5.1755","article-title":"Interleukin 12 signaling in T helper type 1 (Th1) cells involves tyrosine phosphorylation of signal transducer and activator of transcription (Stat)3 and Stat4.","volume":"181","author":"Jacobson","year":"1995","journal-title":"J Exp Med"},{"issue":"6587","key":"2019111810033750000_B29","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1038\/382174a0","article-title":"Impaired IL-12 responses and enhanced development of Th2 cells in Stat4-deficient mice.","volume":"382","author":"Kaplan","year":"1996","journal-title":"Nature"},{"issue":"6587","key":"2019111810033750000_B30","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1038\/382171a0","article-title":"Requirement for Stat4 in interleukin-12-mediated responses of natural killer and T cells.","volume":"382","author":"Thierfelder","year":"1996","journal-title":"Nature"},{"issue":"4","key":"2019111810033750000_B31","doi-asserted-by":"crossref","first-page":"1708","DOI":"10.4049\/jimmunol.160.4.1708","article-title":"IL-1 alpha and TNF-alpha are required for IL-12-induced development of Th1 cells producing high levels of IFN-gamma in BALB\/c but not C57BL\/6 mice.","volume":"160","author":"Shibuya","year":"1998","journal-title":"J Immunol"},{"issue":"5","key":"2019111810033750000_B32","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1080\/10799890903078473","article-title":"Functional antagonism of IL-1alpha induced gene expression profiles define the cAMP\/PKA pathway as a unique regulator of IL-1alpha signaling networks.","volume":"29","author":"Murray","year":"2009","journal-title":"J Recept Signal Transduct Res"},{"issue":"2","key":"2019111810033750000_B33","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1097\/00005792-200103000-00005","article-title":"Infections in patients with immunodeficiency with thymoma (Good syndrome). Report of 5 cases and review of the literature.","volume":"80","author":"Tarr","year":"2001","journal-title":"Medicine (Baltimore)"},{"issue":"26","key":"2019111810033750000_B34","doi-asserted-by":"crossref","first-page":"2527","DOI":"10.1056\/NEJMra023226","article-title":"Pulmonary alveolar proteinosis.","volume":"349","author":"Trapnell","year":"2003","journal-title":"N Engl J Med"},{"issue":"2","key":"2019111810033750000_B35","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1084\/jem.20091983","article-title":"Autoantibodies against IL-17A, IL-17F, and IL-22 in patients with chronic mucocutaneous candidiasis and autoimmune polyendocrine syndrome type I.","volume":"207","author":"Puel","year":"2010","journal-title":"J Exp Med"},{"issue":"2","key":"2019111810033750000_B36","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1084\/jem.20091669","article-title":"Chronic mucocutaneous candidiasis in APECED or thymoma patients correlates with autoimmunity to Th17-associated cytokines.","volume":"207","author":"Kisand","year":"2010","journal-title":"J Exp Med"},{"issue":"7","key":"2019111810033750000_B37","doi-asserted-by":"crossref","first-page":"1543","DOI":"10.1084\/jem.20080321","article-title":"Mutations in STAT3 and IL12RB1 impair the development of human IL-17-producing T cells.","volume":"205","author":"de Beaucoudrey","year":"2008","journal-title":"J Exp Med"},{"issue":"18","key":"2019111810033750000_B38","doi-asserted-by":"crossref","first-page":"1760","DOI":"10.1056\/NEJMoa0901053","article-title":"Human dectin-1 deficiency and mucocutaneous fungal infections.","volume":"361","author":"Ferwerda","year":"2009","journal-title":"N Engl J Med"},{"issue":"18","key":"2019111810033750000_B39","doi-asserted-by":"crossref","first-page":"1727","DOI":"10.1056\/NEJMoa0810719","article-title":"A homozygous CARD9 mutation in a family with susceptibility to fungal infections.","volume":"361","author":"Glocker","year":"2009","journal-title":"N Engl J Med"},{"issue":"16","key":"2019111810033750000_B40","doi-asserted-by":"crossref","first-page":"1608","DOI":"10.1056\/NEJMoa073687","article-title":"STAT3 mutations in the hyper-IgE syndrome.","volume":"357","author":"Holland","year":"2007","journal-title":"N Engl J Med"},{"issue":"7188","key":"2019111810033750000_B41","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1038\/nature06764","article-title":"Impaired T(H)17 cell differentiation in subjects with autosomal dominant hyper-IgE syndrome.","volume":"452","author":"Milner","year":"2008","journal-title":"Nature"},{"issue":"2","key":"2019111810033750000_B42","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/S0889-8529(01)00013-5","article-title":"APS-I\/APECED: the clinical disease and therapy.","volume":"31","author":"Perheentupa","year":"2002","journal-title":"Endocrinol Metab Clin North Am"},{"issue":"5597","key":"2019111810033750000_B43","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.1126\/science.1075958","article-title":"Projection of an immunological self shadow within the thymus by the aire protein.","volume":"298","author":"Anderson","year":"2002","journal-title":"Science"},{"issue":"3","key":"2019111810033750000_B44","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1111\/j.1365-2249.2007.03442.x","article-title":"Expression of autoimmune regulator gene (AIRE) and T regulatory cells in human thymomas.","volume":"149","author":"Scarpino","year":"2007","journal-title":"Clin Exp Immunol"},{"issue":"5","key":"2019111810033750000_B45","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1002\/path.2141","article-title":"Deficiency of the autoimmune regulator AIRE in thymomas is insufficient to elicit autoimmune polyendocrinopathy syndrome type 1 (APS-1).","volume":"211","author":"Strobel","year":"2007","journal-title":"J Pathol"},{"issue":"5","key":"2019111810033750000_B46","doi-asserted-by":"crossref","first-page":"2610","DOI":"10.1073\/pnas.0337679100","article-title":"Interferon-inducible gene expression signature in peripheral blood cells of patients with severe lupus.","volume":"100","author":"Baechler","year":"2003","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"6","key":"2019111810033750000_B47","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1084\/jem.20021553","article-title":"Interferon and granulopoiesis signatures in systemic lupus erythematosus blood.","volume":"197","author":"Bennett","year":"2003","journal-title":"J Exp Med"}],"container-title":["Blood"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/ashpublications.org\/blood\/article-pdf\/116\/23\/4848\/1332058\/zh804910004848.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/ashpublications.org\/blood\/article-pdf\/116\/23\/4848\/1332058\/zh804910004848.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,3,29]],"date-time":"2024-03-29T17:39:49Z","timestamp":1711733989000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/blood\/article\/116\/23\/4848\/28291\/Anticytokine-autoantibodies-are-associated-with"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,12,2]]},"references-count":47,"journal-issue":{"issue":"23","published-print":{"date-parts":[[2010,12,2]]}},"URL":"https:\/\/doi.org\/10.1182\/blood-2010-05-286161","relation":{},"ISSN":["0006-4971","1528-0020"],"issn-type":[{"value":"0006-4971","type":"print"},{"value":"1528-0020","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,12,2]]}}}